Genenta Science
  • who we are
  • our companies
  • stories
  • investors
Select Page

Genenta, Commissione UE concede Orphan Drug Designation a Temferon

Mar 13, 2026

Genenta, AIFA approva sperimentazione innovativa per carcinoma renale metastatico

Oct 1, 2024

Nuovo finanziamento per Genenta, la startup che vuole curare i tumori

Sep 13, 2017

CONTACT
NEWSROOM
© 2026 Genenta Science. All Rights Reserved - Terms and conditions - Privacy Policy - Whistleblowing - P.IVA 08738490963